Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06601894

The Relationship of Platelet Counts With Sickle Cell Anemia in the Eastern Region of Saudi Arabia

This study aims to evaluate the relationship between platelet counts and sickle cell disease in the eastern region of the Kingdom of Saudi Arabia.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Sickle Cell Anaemia Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Anemia, Sickle Cell Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinopathies SCD

Age range

1 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Khalid Ali Majrashi

Dammam, Saudi Arabia

Location contact

KHALID A MAJRASHI

PRINCIPAL_INVESTIGATOR

MOHAMMED A Eidaroos, PHD

CONTACT

[email protected]

0164042900

About this study

Introduction:

This study aims to evaluate the relationship between platelet counts and sickle cell disease in the eastern region of the Kingdom of Saudi Arabia.

Purpose: This study aims to assess the prevalence and factors associated with elevated platelet counts in people with sickle cell disease in the eastern region of Saudi Arabia.

Methods: This cross-sectional study at Majmaah University will analyze prerecorded data frfom the eastern region of Saudi Arabia to investigate the relationship between platelet counts and sickle cell disease, identifying associated factors and assessing the link .

Importance: To assess the relationship between platelet counts and disease severity in Pationt with SCD.

Aim :To investigate the relationship between platelet counts and SCD in the eastern region of the Kingdom of Saudi Arabia.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All the diagnosed patients of sickle cell disease regardless of age and gender.

Exclusion criteria

Patients without having sickle cell disease regardless of age and gender.

Treatment and study plan

Platelets count

Diagnostic Test

the study include will take medical investigation data for all sickle cell patients.

Primary outcomes

  1. Collecting platelet data for sickle cell anemia patients

    Time frame: From January 2023 to December 2023

    Collecting platelet data for sickle cell anemia patients in males and female and children based on different ages, then analyzing them and studying their relationship

Study contacts

Contact information is provided by the study sponsor or research team.

Khalid A Majrashi

CONTACT

[email protected]

0533489978

Sponsors and collaborators

Lead sponsor

Majmaah University

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Sep 19, 2024
Registry last updated
Oct 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.